BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21251545)

  • 1. Omega-3 polyunsaturated fatty acids and clinical trials.
    Svensson M; Jørgensen KA; Christensen JH
    Am J Kidney Dis; 2011 Feb; 57(2):352; author reply 353. PubMed ID: 21251545
    [No Abstract]   [Full Text] [Related]  

  • 2. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease.
    Fassett RG; Gobe GC; Peake JM; Coombes JS
    Am J Kidney Dis; 2010 Oct; 56(4):728-42. PubMed ID: 20493605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.
    Verboom CN;
    Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid-correcting effect of marine unsaturated fatty acids for prophylaxis of cardiovascular diseases in boys].
    Kozycheva EV; Slezka IE
    Vopr Pitan; 1998; (4):27-31. PubMed ID: 9825470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside.
    De Caterina R; Madonna R; Zucchi R; La Rovere MT
    Am Heart J; 2003 Sep; 146(3):420-30. PubMed ID: 12947358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. n-3 Polyunsaturated fatty acids are still underappreciated and underused post myocardial infarction.
    Khavandi A; Khavandi K; Greenstein A; Karsch K; Heagerty AM
    Heart; 2009 Apr; 95(7):540-1. PubMed ID: 19131442
    [No Abstract]   [Full Text] [Related]  

  • 7. Highly purified omega-3 polyunsaturated fatty acids in clinical development.
    Vik H
    Herz; 2006 Dec; 31 Suppl 3():83-95. PubMed ID: 17575810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of omega-3 fatty acids on renal diseases: are they justified?].
    Hernández D; García S; González A; Rufino M; Salido E; Torres A
    Nefrologia; 2005; 25(3):221-32. PubMed ID: 16053003
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.
    Marchioli R; Marfisi RM; Borrelli G; Chieffo C; Franzosi MG; Levantesi G; Maggioni AP; Nicolosi GL; Scarano M; Silletta MG; Schweiger C; Tavazzi L; Tognoni G
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S34-7. PubMed ID: 17876196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
    Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH
    Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thanks to cardioprotective omega-3 fatty acids. To live longer with cod-liver oil].
    MMW Fortschr Med; 2002 Oct; 144(41):59. PubMed ID: 12474370
    [No Abstract]   [Full Text] [Related]  

  • 12. [Omega-3 fatty acids and cardiovascular diseases].
    Daubresse JC; Sternon J
    Rev Med Brux; 2006; 27(1):43-8. PubMed ID: 16608011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega 3 fatty acids in renal diseases.
    De Caterina R
    World Rev Nutr Diet; 1994; 76():137-42. PubMed ID: 7856224
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary prevention of coronary artery disease with omega-3 fatty acids.
    Jacobson TA
    Am J Cardiol; 2006 Aug; 98(4A):61i-70i. PubMed ID: 16919518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of omega-3 fatty acids and the prevention of coronary heart disease.
    Harper CR; Jacobson TA
    Am J Cardiol; 2005 Dec; 96(11):1521-9. PubMed ID: 16310434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Omega-3 fatty acids in cardiology. Latest developments].
    von Schacky C
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():97-101. PubMed ID: 17955786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-3 fatty acids: priority for post-myocardial infarction clinical trials.
    Grundy SM
    Circulation; 2003 Apr; 107(14):1834-6. PubMed ID: 12695281
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of omega-3 fatty acids in renal disorders.
    Plotnick AN
    J Am Vet Med Assoc; 1996 Sep; 209(5):906-10. PubMed ID: 8790537
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiarrhythmic effects of n-3 polyunsaturated fatty acids.
    Wongcharoen W; Chattipakorn N
    Asia Pac J Clin Nutr; 2005; 14(4):307-12. PubMed ID: 16326636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Highly concentrated omega-3-fatty acids. A new means in the secondary prevention].
    MMW Fortschr Med; 2005 Oct; 147(43):60-1. PubMed ID: 16302426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.